GLP1R and diabetes mellitus: A consensus statement from the American Diabetes Association, European Association for the Study of Diabetes, and Chinese Diabetes Society recommends the administration of glucagon-like peptide-1 receptor agonists or SGLT-2i in patients whose blood glucose levels are inadequately controlled with metformin [14].